Alpha6beta2 nicotinic acetylcholine receptors (nAChRs) are potential therapeutic targets for the treatment of several neuropsychiatric diseases, including addiction and Parkinson’s disease. Alpha-conotoxin (α-CTx) TxIB is a uniquely selective ligand, which blocks α6/α3β2β3 nAChRs only, but does not block the other subtypes. Therefore, α-CTx TxIB is a valuable therapeutic candidate peptide. Synthesizing enough α-CTx TxIB with high yield production is required for conducting wide-range testing of its potential medicinal applications. The current study optimized the cleavage of synthesized α-CTx TxIB resin-bounded peptide and folding of the cleaved linear peptide. Key parameters influencing cleavage and oxidative folding of α-CTx TxIB were examined, such as buffer, redox agents, pH, salt, co-solvent and temperature. Twelve conditions were used for cleavage optimization. Fifty-four kinds of one-step oxidative solution were used to assess their effects on each α-CTx TxIB isomers’ yield. The result indicated that co-solvent choices were particularly important. Completely oxidative folding of globular isomer was achieved when the NH 4HCO 3 or Tris-HCl folding buffer at 4 °C contained 40% of co-solvent DMSO, and GSH:GSSG (2:1) or GSH only with pH 8~8.7.
References
[1]
Albuquerque, E.X.; Pereira, E.F.; Alkondon, M.; Rogers, S.W. Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol. Rev. 2009, 89, 73–120, doi:10.1152/physrev.00015.2008.
[2]
Millar, N.S.; Gotti, C. Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology 2009, 56, 237–246, doi:10.1016/j.neuropharm.2008.07.041.
Quik, M.; Perez, X.A.; Grady, S.R. Role of α6 nicotinic receptors in CNS dopaminergic function: Relevance to addiction and neurological disorders. Biochem. Pharmacol. 2011, 82, 873–882, doi:10.1016/j.bcp.2011.06.001.
[5]
Luo, S.; Christensen, S.; Zhangsun, D.; Wu, Y.; Hu, Y.; Zhu, X.; Chhabra, S.; Norton, R.S.; McIntosh, J.M. A novel inhibitor of alpha9alpha10 nicotinic acetylcholine receptors from Conus vexillum delineates a new conotoxin superfamily. PLoS ONE 2013, 8, e54648.
[6]
Lewis, R.J.; Garcia, M.L. Therapeutic potential of venom peptides. Nat. Rev. Drug Discov. 2003, 2, 790–802, doi:10.1038/nrd1197.
Lopez-Vera, E.; Aguilar, M.B.; Schiavon, E.; Marinzi, C.; Ortiz, E.; Restano Cassulini, R.; Batista, C.V.; Possani, L.D.; Heimer de la Cotera, E.P.; Peri, F.; et al. Novel alpha-conotoxins from Conus spurius and the alpha-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcholine receptors. FEBS J. 2007, 274, 3972–3985, doi:10.1111/j.1742-4658.2007.05931.x.
[12]
Klink, R.; de Kerchove d’Exaerde, A.; Zoli, M.; Changeux, J.P. Molecular and physiological diversity of nicotinic acetylcholine receptors in the midbrain dopaminergic nuclei. J. Neurosci. 2001, 21, 1452–1463.
[13]
Livett, B.G.; Sandall, D.W.; Keays, D.; Down, J.; Gayler, K.R.; Satkunanathan, N.; Khalil, Z. Therapeutic applications of conotoxins that target the neuronal nicotinic acetylcholine receptor. Toxicon 2006, 48, 810–829, doi:10.1016/j.toxicon.2006.07.023.
[14]
Gehrmann, J.; Alewood, P.F.; Craik, D.J. Structure determination of the three disulfide bond isomers of α-conotoxin GI: A model for the role of disulfide bonds in structural stability. J. Mol. Biol. 1998, 278, 401–415, doi:10.1006/jmbi.1998.1701.
[15]
Luo, S.; Zhangsun, D.; Wu, Y.; Zhu, X.; Hu, Y.; McIntyre, M.; Christensen, S.; Akcan, M.; Craik, D.J.; McIntosh, J.M. Characterization of a Novel alpha-Conotoxin from Conus textile that Selectively Targets Alpha6/alpha3beta2betab3 Nicotinic Acetylcholine Receptors. J. Biol. Chem. 2013, 288, 894–902, doi:10.1074/jbc.M112.427898.
[16]
Guy, C.A.; Fields, G.B. Trifluoroacetic acid cleavage and deprotection of resin-bound peptides following synthesis by Fmoc chemistry. Methods Enzymol. 1997, 289, 67–83, doi:10.1016/S0076-6879(97)89044-1.
[17]
Fields, C.G.; Fields, G.B. Minimization of tryptophan alkylation following 9-fluorenylmethoxycarbonyl solid-phase peptide synthesis. Tetrahedron Lett. 1993, 34, 6661–6664, doi:10.1016/S0040-4039(00)61669-6.
[18]
King, D.S.; Fields, C.G.; Fields, G.B. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res. 1990, 36, 255–266.
[19]
Pearson, D.A.; Blanchette, M.; Baker, M.L.; Guindon, C.A. Trialkylsilanes as scavengers for the trifluoroacetic acid deblocking of protecting groups in peptide synthesis. Tetrahedron Lett. 1989, 30, 2739–2742, doi:10.1016/S0040-4039(00)99113-5.
[20]
Bulaj, G.; Olivera, B.M. Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides. Antioxid. Redox Signal. 2008, 10, 141–155, doi:10.1089/ars.2007.1856.
[21]
DeLa Cruz, R.; Whitby, F.G.; Buczek, O.; Bulaj, G. Detergent-assisted oxidative folding of delta-conotoxins. J. Pept. Res. 2003, 61, 202–212, doi:10.1034/j.1399-3011.2003.t01-1-00048.x.
[22]
Gyanda, R.; Banerjee, J.; Chang, Y.P.; Phillips, A.M.; Toll, L.; Armishaw, C.J. Oxidative folding and preparation of alpha-conotoxins for use in high-throughput structure-activity relationship studies. J. Pept. Sci. 2012, 19, 16–24.
[23]
Konermann, L.; Stocks, B.B.; Pan, Y.; Tong, X. Mass spectrometry combined with oxidative labeling for exploring protein structure and folding. Mass Spectrom. Rev. 2010, 29, 651–667.
[24]
Salamanca, S.; Chang, J.Y. Unfolding and refolding pathways of a major kinetic trap in the oxidative folding of alpha-lactalbumin. Biochemistry 2005, 44, 744–750, doi:10.1021/bi048182n.
[25]
Wong, C.T.T.; Taichi, M.; Nishio, H.; Nishiuchi, Y.; Tam, J.P. Optimal Oxidative Folding of the Novel Antimicrobial Cyclotide from Hedyotis biflora Requires High Alcohol Concentrations. Biochemistry 2011, 50, 7275–7283, doi:10.1021/bi2007004.
Leta Aboye, T.; Clark, R.J.; Craik, D.J.; Goransson, U. Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2. Chembiochem. 2008, 9, 103–113, doi:10.1002/cbic.200700357.
[28]
Steiner, A.M.; Bulaj, G. Optimization of oxidative folding methods for cysteine-rich peptides: a study of conotoxins containing three disulfide bridges. J. Pept. Sci. 2011, 17, 1–7, doi:10.1002/psc.1283.
[29]
Fuller, E.; Green, B.R.; Catlin, P.; Buczek, O.; Nielsen, J.S.; Olivera, B.M.; Bulaj, G. Oxidative folding of conotoxins sharing an identical disulfide bridging framework. FEBS J. 2005, 272, 1727–1738, doi:10.1111/j.1742-4658.2005.04602.x.
[30]
Bulaj, G.; Buczek, O.; Goodsell, I.; Jimenez, E.C.; Kranski, J.; Nielsen, J.S.; Garrett, J.E.; Olivera, B.M. Efficient oxidative folding of conotoxins and the radiation of venomous cone snails. Proc. Natl. Acad. Sci. USA 2003, 100 (Suppl. 2), 14562–14568, doi:10.1073/pnas.2335845100.
[31]
Zhang, R.M.; Snyder, G.H. Factors governing selective formation of specific disulfides in synthetic variants of alpha-conotoxin. Biochemistry 1991, 30, 11343–11348, doi:10.1021/bi00111a021.
[32]
Nielsen, J.S.; Buczek, P.; Bulaj, G. Cosolvent-assisted oxidative folding of a bicyclic alpha-conotoxin ImI. J. Pept. Sci. 2004, 10, 249–256, doi:10.1002/psc.531.
[33]
Grishin, A.A.; Wang, C.I.; Muttenthaler, M.; Alewood, P.F.; Lewis, R.J.; Adams, D.J. Alpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors. J. Biol. Chem. 2010, 285, 22254–22263.
[34]
Clark, R.J.; Daly, N.L.; Halai, R.; Nevin, S.T.; Adams, D.J.; Craik, D.J. The three-dimensional structure of the analgesic alpha-conotoxin, RgIA. FEBS Lett. 2008, 582, 597–602, doi:10.1016/j.febslet.2008.01.027.
[35]
Anderson, M.E.; Meister, A. Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis. Proc. Natl. Acad. Sci. USA 1983, 80, 707–711, doi:10.1073/pnas.80.3.707.
[36]
Aboye, T.L.; Clark, R.J.; Burman, R.; Roig, M.B.; Craik, D.J.; Goransson, U. Interlocking disulfides in circular proteins: toward efficient oxidative folding of cyclotides. Antioxid. Redox Signal. 2011, 14, 77–86, doi:10.1089/ars.2010.3112.
[37]
Kubo, S.; Chino, N.; Kimura, T.; Sakakibara, S. Oxidative folding of omega-conotoxin MVIIC: Effects of temperature and salt. Biopolymers 1996, 38, 733–744, doi:10.1002/(SICI)1097-0282(199606)38:6<733::AID-BIP5>3.0.CO;2-S.
[38]
Tam, J.P.; Wu, C.R.; Liu, W.; Zhang, J.W. Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and applications. J. Am. Chem. Soc. 1991, 113, 6657–6662, doi:10.1021/ja00017a044.
[39]
Bulaj, G.; Kortemme, T.; Goldenberg, D.P. Ionization-reactivity relationships for cysteine thiols in polypeptides. Biochemistry 1998, 37, 8965–8972, doi:10.1021/bi973101r.
Kubo, S.; Tanimura, K.; Nishio, H.; Chino, N.; Teshima, T.; Kimura, T.; Nishiuchi, Y. Optimization of the Oxidative Folding Reaction and Disulfide Structure Determination of Human α-Defensin 1, 2, 3 and 5. Int. J. Pept. Res. Ther. 2008, 14, 341–349, doi:10.1007/s10989-008-9146-z.
[42]
Daly, N.L.; Craik, D.J. Acyclic permutants of naturally occurring cyclic proteins Characterization of cystine knot and β-sheet formation in the macrocyclic polypeptide kalata B1. J. Biol. Chem. 2000, 275, 19068–19075, doi:10.1074/jbc.M000450200.
[43]
Shimizu, S.; Shimizu, K. Alcohol denaturation: thermodynamic theory of peptide unit solvation. J. Am. Chem. Soc. 1999, 121, 2387–2394, doi:10.1021/ja982560s.
[44]
Welker, E.; Narayan, M.; Wedemeyer, W.J.; Scheraga, H.A. Structural determinants of oxidative folding in proteins. Proc. Natl. Acad. Sci. USA 2001, 98, 2312–2316, doi:10.1073/pnas.041615798.
